| 000 | 04086na a2200901 4500 | ||
|---|---|---|---|
| 999 |
_c14010 _d14010 |
||
| 003 | PC14010 | ||
| 005 | 20181102133317.0 | ||
| 008 | 130622s2013 xxx||||| |||| 00| 0 eng d | ||
| 040 | _cH12O | ||
| 041 | _aeng | ||
| 100 |
_aCarreira Delgado, Patricia Esmeralda _9467 _eReumatología |
||
| 245 | 0 | 0 |
_aImplication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. _h[artículo] |
| 260 |
_bAnnals of the rheumatic diseases, _c2013 |
||
| 300 | _a72(7):1233-8. | ||
| 500 | _aFormato Vancouver: Díaz-Gallo LM, Simeón CP, Broen JC, Ortego-Centeno N, Beretta L, Vonk MCet al. Spanish Scleroderma Group. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis. 2013 Jul;72(7):1233-8. | ||
| 501 | _aPMID: 23172754 | ||
| 504 | _aContiene 36 referencias | ||
| 520 | _aOBJECTIVE: The interleukin 2 (IL-2) and interleukin 21 (IL-21) locus at chromosome 4q27 has been associated with several autoimmune diseases, and both genes are related to immune system functions. The aim of this study was to evaluate the role of the IL-2/IL-21 locus in systemic sclerosis (SSc). | ||
| 710 |
_9123 _aServicio de Reumatología |
||
| 856 |
_uhttp://pc-h12o-es.m-hdoct.a17.csinet.es/pdf/pc/1/pc14010.pdf _ySolicitar documento |
||
| 942 |
_n0 _2ddc _cART |
||